Statistics for Med Investments

6Total Devices

1Basic UDI-DIs

0Not destined for EU market

0Certificates

0Valid

0Expiring < 6 months

1Countries

Certificate health for Med Investments

No certificates registered for this manufacturer.

Devices by risk class

Device catalog for Med Investments

Showing 1–6 of 6 devices.

Trade name	Reference / catalog number	UDI-DI code	Quantity	Status
5046001	`5046001`	`05902729057301`	100	On the market
5046006	`5046006`	`05902729057400`	100	On the market
5046004	`5046004`	`05902729057332`	100	On the market
5046005	`5046005`	`05902729057349`	100	On the market
5046002	`5046002`	`05902729057318`	100	On the market
5046003	`5046003`	`05902729057325`	100	On the market

Device families (Basic UDI-DI) of Med Investments

Showing 1–1 of 1 device families.

velo nitrile590272905VNCMV

Market presence of Med Investments

Devices placed in 1 country

Poland6

EUDAMED update: Dec 28, 2024

Med Investments Spółka z ograniczoną odpowiedzialnością Sp. j.

PL-MF-000004327

Active

Address: Częstochowska, 38/52 93-121 Łódź
Role: Manufacturer
Date of registration: May 14, 2021
Country: PL Poland

About Med Investments

SRN: PL-MF-000004327
Role: Manufacturer
Country: Poland
Organization name: Med Investments Spółka z ograniczoną odpowiedzialnością Sp. j.
EU VAT number: 7282790116
EORI: PL728279011600000
Date of registration: May 14, 2021

Contact details for Med Investments

Address: 38/52, CZĘSTOCHOWSKA 93-121 ŁÓDŹ POLAND
Email: info@medinvestments.pl

Validator

Name: Urząd Rejestracji Produktów Leczniczych
SRN: PL-CA-014
Phone: +48 22 492 11 71
Email: wm@urpl.gov.pl

Officers and regulatory representatives of Med Investments

ROŁKA Katarzyna
ensuring that: the conformity of the devices is checked in accordance with the quality management system before a device is released, the technical documentation and the EU declaration of conformity are drawn up and kept up-to-date; the post-market surveillance obligations are complied; the reporting obligations referred to in Articles 87 to 91 of MDR are fulfilled; in the case of investigational devices, the statement referred to in Section 4.1 of Chapter II of Annex XV of MDR is issued.
Hidden

Become a partner of MD Atlas